576 related articles for article (PubMed ID: 29249461)
1. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
2. Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications.
Tsoras AN; Champion JA
Annu Rev Chem Biomol Eng; 2019 Jun; 10():337-359. PubMed ID: 31173518
[TBL] [Abstract][Full Text] [Related]
3. Introduction to checkpoint inhibitors and cancer immunotherapy.
Sharpe AH
Immunol Rev; 2017 Mar; 276(1):5-8. PubMed ID: 28258698
[No Abstract] [Full Text] [Related]
4. [Immunology. Realizable discoveries].
Kabelitz D
Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1570-2. PubMed ID: 10664659
[No Abstract] [Full Text] [Related]
5. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells: Multi-talented immune suppressive cells that can be either helpful or harmful.
Cell Immunol; 2021 Jul; 365():104374. PubMed ID: 34038759
[No Abstract] [Full Text] [Related]
7. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.
Deo YM; Graziano RF; Repp R; van de Winkel JG
Immunol Today; 1997 Mar; 18(3):127-35. PubMed ID: 9078685
[TBL] [Abstract][Full Text] [Related]
8. Engineering Immune Tolerance with Biomaterials.
Gammon JM; Jewell CM
Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Strategies for Modulating T Cell Responses in Autoimmunity and Infection.
Pascutti MF; Martinez GJ; Quiroga MF
Front Immunol; 2020; 11():208. PubMed ID: 32153569
[No Abstract] [Full Text] [Related]
10. Revisiting the Functional Impact of NK Cells.
Poli A; Michel T; Patil N; Zimmer J
Trends Immunol; 2018 Jun; 39(6):460-472. PubMed ID: 29496432
[TBL] [Abstract][Full Text] [Related]
11. Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.
Li PY; Fan Z; Cheng H
Bioconjug Chem; 2018 Mar; 29(3):624-634. PubMed ID: 29323870
[TBL] [Abstract][Full Text] [Related]
12. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
Zhang PF; Xie D; Li Q
Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in regulatory T cell therapy of autoimmunity, graft rejection and cancer.
Dunne PJ; Fletcher JM
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):231-43. PubMed ID: 20812898
[TBL] [Abstract][Full Text] [Related]
15. Applications of chemokines as adjuvants for vaccine immunotherapy.
Mohan T; Zhu W; Wang Y; Wang BZ
Immunobiology; 2018; 223(6-7):477-485. PubMed ID: 29246401
[TBL] [Abstract][Full Text] [Related]
16. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
[TBL] [Abstract][Full Text] [Related]
17. Engineering self-assembled materials to study and direct immune function.
Tostanoski LH; Jewell CM
Adv Drug Deliv Rev; 2017 May; 114():60-78. PubMed ID: 28392305
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccines and immunotherapies: current challenges and new frontiers.
Oviedo-Orta E; Plotkin SA; Ulmer JB; Ahmed SS
Expert Rev Vaccines; 2013 Mar; 12(3):243-4. PubMed ID: 23496662
[No Abstract] [Full Text] [Related]
19. Current Opinion in Immunology. Vaccines. Introduction.
Ertl HC; Lanzavecchia A
Curr Opin Immunol; 2010 Jun; 22(3):355-7. PubMed ID: 20510596
[TBL] [Abstract][Full Text] [Related]
20. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
Shah SA; Oakes RS; Jewell CM
Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
